Calcium is a vital mineral that plays a crucial role in various physiological processes. This article aims to delve into its significance in bone metabolism, providing a comprehensive understanding for healthcare professionals.
Calcium is the primary component of bones and teeth, constituting approximately 99% of the body's total calcium. It aids in the construction of a healthy skeletal system and the maintenance of bone density, thereby preventing osteoporosis and fractures.
Calcium homeostasis, regulated by hormones such as parathyroid hormone (PTH), vitamin D, and calcitonin, is integral to bone metabolism. The interplay between these hormones ensures a constant level of calcium in the blood, which is crucial for normal cellular functions. Any disruption in this balance can lead to bone diseases.
The absorption of dietary calcium is a critical process that occurs predominantly in the duodenum and jejunum. It is facilitated by active transport and passive diffusion, with vitamin D playing a pivotal role in the former. Factors such as age, vitamin D status, and dietary components can significantly influence calcium absorption.
Calcium supplementation is often recommended for individuals at risk of osteoporosis or those with inadequate dietary intake. However, the benefits and risks of calcium supplements should be carefully considered, as excessive intake can lead to hypercalcemia and kidney stones.
In conclusion, calcium plays a vital role in bone metabolism and overall bone health. Understanding the mechanisms of calcium homeostasis, absorption, and the implications of supplementation is crucial for healthcare professionals in managing bone health effectively. Continuous research in this field will further elucidate the complex role of calcium in bone metabolism.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation